Astaxanthin with AstaReal 6 mg

Astaxanthin with AstaReal 6 mg

Doctor's Best4.7 (3,551 ratings)
Format:Softgel Quantity: 90 Softgel(s) · 90 servings
Goals

Product analysis

73 out of 100

Astaxanthin with AstaReal 6 mg offers limited support for maintaining skin condition at a favourable ingredient cost. The findings come from small studies, which limits confidence in the likely benefit.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Astaxanthin is named, making the ingredient identity clear. There is not enough information for a reliable comparison of its preparation quality.

Ingredient Transparency100

The listed amounts are disclosed, helping compare servings. The named forms also make ingredient identity clear.

Value For Money100

The astaxanthin compares favourably on cost for the declared amount. The single-ingredient formula keeps the comparison straightforward.

Customer Satisfaction87

Customer ratings are generally positive across a substantial review base. The feedback does not establish effectiveness or safety.

Product Focus55

The clearest connection is limited support for maintaining skin condition. Cognitive benefits remain uncertain, and the cardiovascular contribution cannot be established.

Format
Softgel
Container
90 Softgel(s)
Per serving
$0.28
Customer rating
4.7 · 3,551 ratings
Report analysis

Goals

Longevity
Impact
High effect
B+ Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic
Astaxanthin · 6 mg

Astaxanthin has limited findings for maintaining skin condition during seasonal deterioration, based on a small study in women.

How this product is rated for Longevity

Ingredient fit83

The saved findings count a range of ingredients and compare their amounts with reference amounts. Ingredient presence and amount alone do not establish anti-aging effects.
Goal fit
The counted ingredients form a focused mixture, although the product is linked to several health purposes.
Dose adequacy
The counted amounts provide partial coverage of the saved references; that comparison does not establish a clinically effective anti-aging dose.

Pathways50

The strongest saved coverage is antioxidant defence. Mechanistic coverage does not demonstrate lifespan extension.
Depth
The strongest saved coverage concerns antioxidant defence, a mechanistic finding rather than evidence of slower human aging.
Breadth
Only antioxidant defence reaches the saved coverage threshold; other routes remain limited.

Evidence82

Astaxanthin leads this finding through limited skin outcomes in women, not evidence of lifespan extension.
Evidence strength
Astaxanthin leads this finding through limited skin outcomes in women, not evidence of lifespan extension.
Studied preparation
The saved preparation check is satisfied for counted amounts; this does not extend trial findings to all aging outcomes.

Formulation logic100

The saved findings show partner coverage and no matched ingredient conflicts. Some amount or preparation limits may still restrict practical relevance.
Partner coverage
The counted ingredients have their required partners or work independently under the saved findings; this does not demonstrate added benefit from combining them.
Conflicts
No ingredient conflict was matched in the supplied findings.
Effective doses
All counted ingredients pass the saved minimum amount threshold, which does not establish a proven anti-aging dose.
Study evidence
Skin Health
Impact
Highest effect
A Ingredient FitC- PathwaysA- EvidenceA+ Formulation Logic
Astaxanthin · 6 mg

Astaxanthin has limited support for maintaining selected skin ageing measures and influencing UV-response markers. Small studies and surrogate outcomes limit expectations; this is not sunscreen-equivalent protection.

How this product is rated for Skin Health

Ingredient fit93

Astaxanthin provides the recognized skin connections. The declared counted amounts receive full recognition.
Goal fit
The recognized ingredients provide a focused skin connection, with links to other goals also affecting focus.
Dose adequacy
The counted amounts receive full recognition; this does not establish greater cosmetic benefit from larger supplement amounts.

Pathways59

The strongest recognized coverage concerns uv antioxidant defence. Coverage is concentrated in one area.
Depth
UV antioxidant defence is the strongest recognized area; the supplied ingredient limitations still constrain practical expectations.
Breadth
One area meets the supplied coverage requirement, leaving limited breadth across other skin outcomes.

Evidence87

Astaxanthin leads the saved evidence finding. Preparation, population and outcome limitations constrain transfer to routine skin benefits.
Evidence strength
Astaxanthin has the strongest recognized evidence among the counted ingredients; its specific limitations determine which skin benefits can be described.
Studied preparation
The saved findings recognize the counted preparations; that does not resolve the supplied context's composition, population or outcome limitations.

Formulation logic100

No required partner is missing and no assessed conflict is recorded among the counted ingredients.
Partner coverage
The counted ingredients do not require an additional missing partner; no extra combination benefit is established.
Conflicts
No assessed conflict is recorded; this does not establish comprehensive interaction testing.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of a clinically effective cosmetic dose.
Study evidence
Inflammation
Impact
Situational effect
D+ Ingredient FitF PathwaysF EvidenceB Formulation Logic
Astaxanthin · 6 mg
Study evidence
Cardiovascular Support
Impact
Situational effect
D+ Ingredient FitF PathwaysF EvidenceB Formulation Logic
Astaxanthin · 6 mg

The source label mentions 6 mg AstaReal astaxanthin, but it does not resolve how much is present per serving. Without that amount, the formula has no confirmed cardiovascular pathway coverage or effective contribution, which limits its support for this goal. The ingredient focus is narrow and no formulation conflicts are identified.

How this product is rated for Cardiovascular Support

Ingredient fit53

Astaxanthin is the only goal-focused ingredient and there are no off-goal actives, though the product is linked to six goals.
Goal fit
The ingredient focus is narrow, but links to six goals reduce its focus somewhat.
Dose adequacy
The AstaReal declaration lacks a usable serving denominator, so the active amount remains unknown.

Pathways0

No cardiovascular pathway receives confirmed contribution from the available active amount.
Depth
None of the tracked pathways has confirmed coverage from an effective dose.
Breadth
No pathway reaches the level needed to count toward the breadth target.

Evidence0

The serving amount is unresolved, leaving no ingredient at an effective dose to support the evidence group.
Evidence strength
No credited ingredient reaches the amount needed to count as effective in this comparison.
Studied preparation
No ingredient is both at an effective dose and confirmed in a studied preparation.

Formulation logic75

No missing partner or matched conflict is identified, but the unresolved amount does not clear the effective-dose cutoff.
Partner coverage
The credited ingredient works alone or has its required partner.
Conflicts
No matched ingredient conflicts appear in the supplied facts.
Effective doses
The unresolved per-serving amount cannot meet the minimum amount used in this comparison.
Study evidence
Eye Health
Impact
Situational effect
D+ Ingredient FitF PathwaysF EvidenceB Formulation Logic
Astaxanthin · 6 mg
Study evidence
Cognitive Support
Impact
High effect
B+ Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Astaxanthin · 6 mg

Astaxanthin has antioxidant activity, but that does not establish better memory or attention. In the supplied older-adult forgetfulness trial, changes did not clearly exceed placebo. The 6 mg serving receives partial saved exposure recognition, which should not be read as a demonstrated effective cognitive dose. The declared material does not resolve the uncertainty in cognitive outcomes.

How this product is rated for Cognitive Support

Ingredient fit83

Astaxanthin is the sole counted ingredient. The 6 mg serving receives partial saved exposure recognition.
Goal fit
Astaxanthin is the sole counted ingredient.
Dose adequacy
The 6 mg serving receives partial saved exposure recognition.

Pathways48

Oxidative and inflammatory protection is the sole represented pathway.
Depth
Oxidative and inflammatory protection is the sole represented pathway.
Breadth
One pathway reaches the saved coverage threshold, leaving other cognitive routes unrepresented.

Evidence79

Astaxanthin has mixed findings without clear superiority to placebo in the supplied trial.
Evidence strength
Astaxanthin has mixed findings without clear superiority to placebo in the supplied trial.
Studied preparation
The counted ingredients receive a saved preparation match; this alone does not demonstrate improved cognition.

Formulation logic100

The counted ingredients meet the saved minimum exposure threshold, with no missing required partner or configured conflict.
Partner coverage
The counted ingredients have no missing required partner; this does not establish an added benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this is not a general safety assessment.
Effective doses
All counted ingredients meet the saved minimum exposure threshold; this does not establish clinically effective cognitive doses.
Study evidence

Ingredients

IngredientAmount per servingScore
AstaReal (Astaxanthin)
6 mg 81
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Astaxanthin · 6 mg OverallScore81
C+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
A serving provides 6 mg of astaxanthin from Haematococcus pluvialis algae, with an AstaReal ingredient claim. At the whole-product price, that works out to about $0.05 per mg of listed astaxanthin.
How this ingredient is rated

Active Ingredient Quality & Bioavailability68

Haematococcus pluvialis is the named algal source, with a branded ingredient also recorded. The claims have not been independently verified.
Biological Source Quality
Haematococcus pluvialis algae is recorded as the source of the astaxanthin.
Formulation Technology
The saved facts do not record a liposomal or water-dispersible formulation claim.
Branded Ingredient Standard
AstaReal is identified as a branded ingredient; the claim has not been independently verified.

Dose, Safety & Label Transparency84

The active astaxanthin amount is stated as 6 mg per serving; packaging protection is not established by the saved facts.
Clinical Potency per Serving
The label declares 6 mg of astaxanthin per serving.
Active Astaxanthin Yield Transparency
The astaxanthin amount itself is declared as 6 mg per serving.
Ingredient Stability & Packaging
The saved facts do not establish whether the packaging protects the ingredient from light.

Value100

At the whole-product price, the cost is about $0.05 per mg of listed astaxanthin.
Price per Milligram of Active Astaxanthin
The evaluated whole-product price corresponds to about $0.05 per mg of astaxanthin.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.
    Ciaraldi TP; Boeder SC; Mudaliar SR; Giovannetti ER; Henry RR; Pettus JH · Diabetes, obesity & metabolism · 2023
    Randomized trial34 participantsCardiovascular Support forAstaxanthin
  2. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
    Wan S; Wu W; Zhang Y; He J; Wang X; An P; Luo J; Zhu Y; Luo Y · Nutrients · 2024
    Meta-analysisCardiovascular Support forAstaxanthin
  3. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.
    Yoshida H; Yanai H; Ito K; Tomono Y; Koikeda T; Tsukahara H; Tada N · Atherosclerosis · 2010
    Randomized trial61 participantsCardiovascular Support forAstaxanthin
  4. Effects of Astaxanthin Supplementation on Glycemic Control and Lipid Profile in Patients With Prediabetes and Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
    Molani-Gol R; Bohlouli Sardroudi S; Rafraf M · Nutrition and metabolic insights · 2026
    Meta-analysis403 participants9 studies pooledCardiovascular Support forAstaxanthin
  5. Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.
    Saeidi A; Nouri-Habashi A; Razi O; Ataeinosrat A; Rahmani H; Mollabashi SS; Bagherzadeh-Rahmani B; Aghdam SM; Khalajzadeh L; Al Kiyumi MH; Hackney AC; Laher I; Heinrich KM; Zouhal H · Nutrients · 2023
    Randomized trial68 participantsCardiovascular Support forAstaxanthin
  6. Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study.
    Katagiri M; Satoh A; Tsuji S; Shirasawa T · Journal of clinical biochemistry and nutrition · 2012
    Randomized trial96 participantsCognitive Support forAstaxanthin
  7. Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals.
    Hayashi M; Ishibashi T; Maoka T · Journal of clinical biochemistry and nutrition · 2020
    Clinical trial54 participantsCognitive Support forAstaxanthin
  8. The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review.
    Queen CJJ; Sparks SA; Marchant DC; McNaughton LR · Nutrients · 2024
    Narrative reviewCognitive Support forAstaxanthin
  9. Effects of Astaxanthin Supplementation on Fatigue, Motor Function and Cognition: A Meta-Analysis of Randomized Controlled Trials.
    Liu C; Dong X; Jia J; Ha M · Biological research for nursing · 2024
    Meta-analysis346 participants11 studies pooledCognitive Support forAstaxanthin
  10. Astaxanthin and improvement of dementia: A systematic review of current clinical trials.
    Utomo NP; Pinzon RT; Latumahina PK; Damayanti KRS · Cerebral circulation - cognition and behavior · 2024
    Systematic reviewCognitive Support forAstaxanthin
  11. Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.
    Tian L; Wen Y; Li S; Zhang P; Wang Y; Wang J; Cao K; Du L; Wang N; Jie Y · Frontiers in nutrition · 2022
    Single-arm trial60 participantsEye Health forAstaxanthin
  12. Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.
    Hecht KA; Marwah M; Wood V; Nishida Y; Bach AE; Gerson J; Hom MM; Schnackenberg J; Raote S; Srivastava S; Negi P; Caston E · Advances in therapy · 2025
    Randomized trial64 participantsEye Health forAstaxanthin
  13. Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.
    Sekikawa T; Kizawa Y; Li Y; Miura N · Journal of clinical biochemistry and nutrition · 2023
    Randomized trial60 participantsEye Health forAstaxanthin
  14. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.
    Kidd P · Alternative medicine review : a journal of clinical therapeutic · 2012
    Narrative reviewEye Health Longevity forAstaxanthin
  15. Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.
    Martinez-Perez C; Oliveira AP · Nutrients · 2026
    Systematic review9 studies pooledEye Health forAstaxanthin
  16. The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial.
    Youssef FM; Ateyya H; Hanna Samy AE; Elmokadem EM · Frontiers in pharmacology · 2025
    Randomized trial80 participantsInflammation forAstaxanthin
  17. The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.
    Malcangi G; Inchingolo AM; Casamassima L; Trilli I; Ferrante L; Longo M; Inchingolo F; Marinelli G; Palermo A; Dipalma G; Inchingolo AD · International journal of molecular sciences · 2026
    Systematic review15 studies pooledInflammation forAstaxanthin
  18. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial.
    Rostami S; Alyasin A; Saedi M; Nekoonam S; Khodarahmian M; Moeini A; Amidi F · Frontiers in endocrinology · 2023
    Randomized trial50 participantsInflammation forAstaxanthin
  19. Astaxanthin Modulates Inflammation in Type 2 Diabetes via Regulation of microRNAs, Lysophosphatidylcholine, and α-Hydroxybutyrate.
    Sharifi-Rigi A; Zal F; Aarabi MH; Dehghani M; Roustaei Rad N; Taghiyar S · International journal of endocrinology · 2025
    Randomized trial50 participantsInflammation forAstaxanthin
  20. Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes.
    Basereh A; Khoramipour K; Hosseini N; HajHosseini M; Khodabakhshi A; Amirkhosravi L; Khoramipour K · Scientific reports · 2025
    Randomized trial90 participantsInflammation forAstaxanthin